Dr. Allyson Campbell Spence, MD, PHD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3801 Miranda Ave, Ste 111 Oncology Dept, Palo Alto, CA 94304 Phone: 650-493-5000 |
Alexander Isaac Salter, MD, PHD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 291 Campus Dr, Palo Alto, CA 94305 Phone: 650-497-8000 |
Dr. Benjamin Kim, M.D., M.PHIL. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |
Dr. Beth Ann Martin, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3801 Miranda Ave, Mc 111, Palo Alto, CA 94304 Phone: 650-493-5000 Fax: 650-856-8024 |
Dr. Allison Walsh Kurian, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 875 Blake Wilbur Dr, Palo Alto, CA 94304 Phone: 650-723-7621 Fax: 650-498-5150 |
Alison Grace Chang, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2905 |
Dr. William Frank Novotny, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: Vapa Health Care Systems, 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 |
Mark Daniel Pegram, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 900 Blake Wilbur Dr, First Floor, Palo Alto, CA 94304 Phone: 650-498-6004 Fax: 650-736-0607 |
Dr. Priyamvadha Chakravarthi, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2905 |
Dr. Danielle Hyunkyung Shin, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |
Dr. Michael Siavash Khodadoust, M.D./PH.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 875 Blake Wilbur Dr, Palo Alto, CA 94304 Phone: 650-498-6000 |
Dr. Christopher John Severyn, M.D., PH.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 Welch Rd Ste 300, Palo Alto, CA 94304 Phone: 650-723-5535 Fax: 650-723-5231 |
Pauline Funchain, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Palo Alto, CA 94304 Phone: 650-723-4000 |
Dr. Eric Kam-chuan Lau, D.O. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2905 |
Dr. Bernard M Fine, MD PHD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 |
News Archive
This year HIV Vaccine Awareness Day comes at the dawn of a true prevention revolution that could finally turn the tide of the AIDS epidemic. AIDS vaccine research is a critical part of that revolution and on this day AVAC calls on donors, policy makers and others to strengthen support for AIDS vaccine research.
Encorium Group, Inc. , a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced that it has extended the expiration date for its pending rights offering from September 30, 2010 to October 15, 2010. The subscription rights may now be exercised at any time prior to 5:00 p.m. ET on Friday, October 15, 2010.
Contrary to popular belief, women do not suddenly start to lose their memory when menopause begins, according to a study presented October 4, 2004, at the 129th annual meeting of the American Neurological Association in Toronto.
New research from the University of Liverpool highlights problems impacting on the cognitive development of children in sub-Saharan Africa.
In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.
› Verified 8 days ago